| GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
|
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, CBR1, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, FABP3, FABP4, FDPS, HSD17B1, HSD17B2, MET, PPARA |
7.90526 |
|
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, FDPS, HSD17B1, HSD17B2 |
7.90526 |
|
[BP] GO:0042221 |
response to chemical
|
ADRA2A, AKR1B1, AXL, CA2, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KCNH2, KDR, MCL1, MMP2, MMP9, PPARA, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR |
7.90526 |
|
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, AOX1, AURKB, AXL, CA12, CA2, CA4, CA7, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FLT3, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, PTPRS, RORC, SLC6A4, SRC, TERT, TYR, XDH |
6.61338 |
|
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, AOX1, AURKB, AXL, CA12, CA2, CA4, CA7, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FLT3, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MMP1, MMP2, PIM1, PPARA, PTPN1, PTPRS, RORC, SLC6A4, SRC, TERT, TYR, XDH |
6.30282 |
|
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CA12, CA2, CA4, CA7, CBR1, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, FDPS, PIM1, PPARA, TYR, XDH |
6.29928 |
|
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, MCL1, MMP2, PPARA, RORC, SLC6A4, SRC, TYR |
5.95406 |
|
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADRA2A, AKR1B1, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, IGF1R, KCNH2, KDR, MCL1, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
5.76743 |
|
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CBR1, CES1, CES2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, FABP4, FDPS, MET, PPARA |
5.3076 |
|
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AXL, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, HSD17B2, IGF1R, MMP2, MMP9, PPARA, RORC, SLC6A4, SRC, TYR |
5.3076 |
|
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, TYR |
5.2453 |
|
[BP] GO:0033993 |
response to lipid
|
AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD17B2, RORC, SLC6A4, SRC, TYR |
5.23581 |
|
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADRA2A, AKR1B1, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, IGF1R, KCNH2, KDR, MCL1, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
5.23581 |
|
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PPARA |
5.21706 |
|
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
5.14341 |
|
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, KDR, PPARA, PTPRS, SRC, TYR |
5.11251 |
|
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
5.07319 |
|
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
5.01049 |
|
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.91024 |
|
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADRA2A, AKR1B1, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, ESR1, FABP3, FABP4, FLT3, HSD17B1, HSD17B2, KCNH2, KDR, MCL1, MET, PPARA, SLC6A2, SLC6A4, SRC, TERT, XDH |
4.79922 |
|
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, RORC, SRC |
4.79653 |
|
[BP] GO:0006805 |
xenobiotic metabolic process
|
CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, RORC |
4.78681 |
|
[BP] GO:0042127 |
regulation of cell proliferation
|
ADRA2A, AKR1B1, CDC25B, CSNK2A1, CYP1B1, ESR1, ESRRA, FABP3, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, SLC6A4, SRC, TERT, XDH |
4.75509 |
|
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, AOX1, AURKB, AXL, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FLT3, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, PTPRS, RORC, SRC, TERT, TYR, XDH |
4.65832 |
|
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.65832 |
|
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, AXL, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KCNH2, KDR, MMP2, MMP9, RORC, SLC6A4, SRC, TERT |
4.65108 |
|
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MMP9, SRC, TERT |
4.65108 |
|
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, AURKB, AXL, CA2, CBR1, CDC25B, CES1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FABP4, FLT3, HSD17B2, KDR, MCL1, MET, MMP2, MMP9, PIM1, PPARA, PTPRS, RORC, SLC6A4, SRC, TERT, TYR |
4.65108 |
|
[BP] GO:0032501 |
multicellular organismal process
|
ADRA2A, AKR1B1, AKR1B10, ALOX5, AXL, CYP19A1, CYP1A2, CYP1B1, ESR1, ESRRB, FABP4, HSD17B2, IGF1R, KCNH2, MCL1, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, RORC, SLC6A2, SLC6A4, SRC, TYR |
4.60359 |
|
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
4.48362 |
|
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, HSD17B1, HSD17B2, TYR, XDH |
4.36129 |
|
[BP] GO:0015701 |
bicarbonate transport
|
CA12, CA14, CA2, CA4, CA7 |
4.21642 |
|
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, CA2, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, PPARA, SLC6A4, SRC |
4.11453 |
|
[BP] GO:0009056 |
catabolic process
|
ACHE, AKR1B10, AOX1, AURKB, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, FABP4, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
4.11171 |
|
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, IGF1R, KDR, MCL1, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TERT, XDH |
4.11171 |
|
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AURKB, AXL, CSNK2A1, IGF1R, KDR, MCL1, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TERT |
4.10258 |
|
[BP] GO:0010647 |
positive regulation of cell communication
|
ADRA2A, AKR1B1, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, KDR, MCL1, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
4.10096 |
|
[BP] GO:0023056 |
positive regulation of signaling
|
ADRA2A, AKR1B1, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, KDR, MCL1, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
4.0816 |
|
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CBR1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
4.06906 |
|
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, AOX1, AURKB, AXL, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FLT3, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, PTPRS, RORC, SRC, TERT, TYR, XDH |
4.04879 |
|
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADRA2A, AKR1B1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, IGF1R, KCNH2, KDR, MCL1, MET, MMP12, MMP9, PIM1, PPARA, PTPN1, PTPRS, RORC, SLC6A4, SRC, TERT, XDH |
3.99637 |
|
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, CA2, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, IGF1R, MMP2, PPARA, SLC6A4, SRC |
3.98372 |
|
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
3.97484 |
|
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, IGF1R, KDR, MCL1, MET, MMP9, PIM1, PTPN1, SRC, TERT, XDH |
3.91668 |
|
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.90891 |
|
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
3.8978 |
|
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AURKB, AXL, CSNK2A1, IGF1R, KDR, MCL1, MET, MMP9, PIM1, PTPN1, SRC, TERT |
3.82008 |
|
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FDPS |
3.81962 |
|
[BP] GO:0014070 |
response to organic cyclic compound
|
CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FLT3, RORC, SLC6A4, SRC, TYR |
3.81636 |
|
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.78888 |
|
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, AURKB, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KCNH2, KDR, MCL1, MMP2, MMP9, PTPN1, RORC, SLC6A4, SRC, TERT |
3.76489 |
|
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, CDC25B, CSNK2A1, ESR1, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, TERT |
3.76214 |
|
[BP] GO:0032787 |
None
|
ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PPARA |
3.74095 |
|
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADRA2A, AKR1B1, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, FLT3, IGF1R, KDR, MCL1, MET, MMP12, MMP9, PTPN1, PTPRS, SLC6A4, SRC, TERT, XDH |
3.73686 |
|
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADRA2A, AKR1B1, AURKB, AXL, CA2, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KCNH2, KDR, MCL1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR |
3.70837 |
|
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADRA2A, AKR1B1, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, FLT3, IGF1R, KDR, MCL1, MET, MMP12, MMP9, PTPN1, PTPRS, SLC6A4, SRC, TERT, XDH |
3.65828 |
|
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.54543 |
|
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FDPS |
3.50071 |
|
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADRA2A, ESR1, ESR2, IGF1R, MCL1, MET, MMP12, MMP9, PTPN1, PTPRS, SLC6A4, SRC, TERT, XDH |
3.50071 |
|
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CES1, CYP19A1, FDPS, HSD17B1, HSD17B2 |
3.49823 |
|
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADRA2A, ESR1, ESR2, IGF1R, MCL1, MET, MMP12, MMP9, PTPN1, PTPRS, SLC6A4, SRC, TERT, XDH |
3.49823 |
|
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, IGF1R, KDR, MCL1, MMP9, PIM1, PTPN1, SRC, TERT, XDH |
3.38157 |
|
[BP] GO:0042592 |
homeostatic process
|
ADRA2A, AKR1B1, AXL, CA12, CA2, CA7, ESR1, FABP3, FABP4, FLT3, KCNH2, MCL1, MET, SRC, TERT |
3.23111 |
|
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADRA2A, AKR1B1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, IGF1R, KCNH2, KDR, MCL1, MET, MMP12, MMP9, PIM1, PPARA, PTPN1, PTPRS, RORC, SLC6A4, SRC, TERT, XDH |
3.20583 |
|
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AURKB, AXL, CSNK2A1, IGF1R, KDR, MCL1, MMP9, PIM1, PTPN1, SRC, TERT |
3.20281 |
|
[BP] GO:0006730 |
one-carbon metabolic process
|
CA12, CA2, CA4, CA7 |
3.19114 |
|
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PIM1, PPARA, TYR |
3.19114 |
|
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, AXL, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, RORC, SLC6A4, SRC |
3.10028 |
|
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, KDR, MCL1, MMP9, PIM1, PPARA, PTPRS, RORC, SRC, TYR |
3.02379 |
|
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.96807 |
|
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.92395 |
|
[BP] GO:0080134 |
regulation of response to stress
|
ADRA2A, CYP19A1, ESR1, FABP4, IGF1R, MCL1, MET, MMP12, MMP2, PPARA, PTPN1, PTPRS, SRC, TERT, XDH |
2.89873 |
|
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADRA2A, CYP1A1, FABP3, FDPS, FLT3, PPARA, RORC, SRC |
2.8893 |
|
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.84125 |
|
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADRA2A, CYP19A1, ESR1, ESR2, IGF1R, MCL1, MET, MMP12, MMP9, PPARA, PTPN1, PTPRS, SRC, TERT, XDH |
2.83085 |
|
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.827 |
|
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.81356 |
|
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PIM1, PPARA, TYR |
2.81264 |
|
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
2.80847 |
|
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADRA2A, AKR1B1, AXL, CSNK2A1, CYP1B1, FLT3, KDR, MCL1, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
2.76006 |
|
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADRA2A, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
2.76006 |
|
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CBR1, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, PIM1, PPARA, TYR |
2.75025 |
|
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.70328 |
|
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADRA2A, AKR1B1, AXL, CSNK2A1, CYP1B1, ESRRA, FABP4, FLT3, KDR, MCL1, MET, MMP12, MMP2, MMP9, PTPN1, SRC, TERT, XDH |
2.70328 |
|
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.68063 |
|
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.68063 |
|
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, ESR1, PPARA, RORC, SLC6A4, SRC |
2.67392 |
|
[BP] GO:0044092 |
negative regulation of molecular function
|
ADRA2A, AURKB, CSNK2A1, CYP1B1, ESR1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
2.67392 |
|
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
2.67319 |
|
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.65522 |
|
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, AXL, CES1, CYP1A1, CYP1B1, KDR, SLC6A4, SRC |
2.65435 |
|
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA2A, ESR1, ESR2, IGF1R, MCL1, MET, MMP12, MMP9, PTPN1, PTPRS, SRC, TERT, XDH |
2.62031 |
|
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, CES1, CYP19A1, CYP1A1, CYP1B1, FDPS, TYR |
2.57238 |
|
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CES1, CSNK2A1, CYP19A1, CYP1A1, FDPS, HSD17B1, HSD17B2 |
2.53411 |
|
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADRA2A, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, IGF1R, KDR, MCL1, MET, MMP9, PTPN1, SRC, XDH |
2.51518 |
|
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.48543 |
|
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, MET, MMP9, PPARA, SRC, TERT |
2.48543 |
|
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.46023 |
|
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.46023 |
|
[BP] GO:0048583 |
regulation of response to stimulus
|
ADRA2A, AKR1B1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, FABP4, FLT3, IGF1R, KDR, MCL1, MET, MMP12, MMP2, MMP9, PPARA, PTPN1, PTPRS, SRC, TERT, XDH |
2.44283 |
|
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.44283 |
|
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADRA2A, AURKB, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
2.44283 |
|
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, HSD17B2, KDR, MMP2, SLC6A4, SRC |
2.39025 |
|
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADRA2A, AURKB, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, FLT3, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SLC6A4, SRC, TERT, XDH |
2.39025 |
|
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, CYP1A1, CYP1B1, FABP3, KCNH2, KDR, SLC6A2, SLC6A4, SRC |
2.39025 |
|
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.3677 |
|
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.3677 |
|
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.35216 |
|
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.31572 |
|
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AXL, CYP1B1, ESR1, IGF1R, MMP2, MMP9, RORC, SLC6A4, SRC |
2.31572 |
|
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.26235 |
|
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, CDC25B, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, SRC |
2.24863 |
|
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADRA2A, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC, TERT |
2.24819 |
|
[BP] GO:0048869 |
cellular developmental process
|
ACHE, AXL, CBR1, CDC25B, CES1, CYP1A1, ESR1, ESRRB, FABP4, FLT3, KDR, MCL1, MET, MMP2, MMP9, PTPRS, RORC, SRC, TERT |
2.24639 |
|
[BP] GO:0009987 |
cellular process
|
ACHE, ADRA2A, AKR1B1, AKR1B10, ALOX5, AOX1, AURKB, AXL, CA12, CA2, CA4, CA7, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FLT3, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MCL1, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, PTPRS, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR, XDH |
2.22616 |
|
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.21835 |
|
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.21835 |
|
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.21835 |
|
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
CYP1A1, CYP1B1, ESR1, FLT3, RORC, SLC6A4, SRC |
2.20111 |
|
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, AURKB, AXL, CDC25B, CSNK2A1, FDPS, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, PTPN1, PTPRS, SRC, XDH |
2.20111 |
|
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.19494 |
|
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADRA2A, AURKB, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, FLT3, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TERT, XDH |
2.16966 |
|
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, TERT |
2.13408 |
|
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADRA2A, AKR1B1, AXL, CYP1B1, FLT3, KDR, MCL1, MET, PTPN1, SRC, XDH |
2.1249 |
|
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.0742 |
|
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, CYP1A1, ESR1, FLT3, MET, PIM1, SRC, TYR |
2.0742 |
|
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.0385 |
|
[BP] GO:0001666 |
response to hypoxia
|
CYP1A1, MMP2, PPARA, SLC6A4, SRC, TERT |
2.02933 |
|
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
ESR1, IGF1R, MCL1, MET, MMP9, PTPN1, SRC, XDH |
2.01802 |
|
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.00222 |
|
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, CES1, CYP19A1, FDPS, TYR |
2.00222 |
|
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, AURKB, AXL, CDC25B, CSNK2A1, FDPS, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, PTPN1, PTPRS, SRC, XDH |
2.00119 |
|
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, AKR1B1, AKR1B10, ALOX5, AOX1, AURKB, CA2, CA4, CA7, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, FABP3, FABP4, FDPS, FLT3, HSD17B1, HSD17B2, KCNH2, KDR, MCL1, MMP2, MMP9, PIM1, PTPN1, PTPRS, SLC6A4, SRC, TERT, TYR, XDH |
1.97299 |
|
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
1.91721 |
|
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, AKR1B1, AKR1B10, AOX1, AURKB, AXL, CA2, CA4, CBR1, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FLT3, IGF1R, KDR, MCL1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, PTPRS, RORC, SRC, TERT, TYR, XDH |
1.42462 |
|
[CC] GO:0043231 |
intracellular membrane-bounded organelle
|
ACHE, AKR1B1, AKR1B10, AURKB, CA4, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FABP4, FDPS, FLT3, IGF1R, KDR, MCL1, MMP12, MMP2, PIM1, PPARA, PTPN1, RORC, SRC, TERT, TYR, XDH |
0.962521 |
|
[CC] GO:0044432 |
endoplasmic reticulum part
|
CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FLT3, HSD17B2, PTPN1 |
0.879747 |
|
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TYR, XDH |
12.8757 |
|
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, AOX1, AURKB, AXL, CA12, CA14, CA2, CA4, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FLT3, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, PTPRS, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR, XDH |
8.72449 |
|
[MF] GO:0003824 |
catalytic activity
|
ACHE, AKR1B1, AKR1B10, ALOX5, AOX1, AURKB, AXL, CA12, CA14, CA2, CA4, CA7, CBR1, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FDPS, FLT3, HSD17B1, HSD17B2, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTPN1, PTPRS, SRC, TERT, TYR, XDH |
7.90526 |
|
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA12, CA14, CA2, CA4, CA7 |
6.08584 |
|
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, AOX1, AURKB, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FDPS, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, TERT, TYR, XDH |
5.62064 |
|
[MF] GO:0008270 |
zinc ion binding
|
CA12, CA2, CA4, CA7, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC |
5.35468 |
|
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.3076 |
|
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.3076 |
|
[MF] GO:0046872 |
metal ion binding
|
ALOX5, AOX1, AURKB, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FDPS, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, TERT, TYR, XDH |
5.30408 |
|
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, HSD17B1, HSD17B2, TYR, XDH |
5.21706 |
|
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, XDH |
5.02968 |
|
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.01565 |
|
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, CBR1, HSD17B1, HSD17B2, XDH |
4.36129 |
|
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD17B1, RORC |
4.21642 |
|
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
4.17551 |
|
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, TYR |
4.04879 |
|
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADRA2A, CSNK2A1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SLC6A4, SRC |
3.97484 |
|
[MF] GO:0016836 |
hydro-lyase activity
|
CA12, CA14, CA2, CA4, CA7 |
3.86415 |
|
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.84124 |
|
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.67858 |
|
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.67554 |
|
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, AOX1, CSNK2A1, ESR1, ESR2, FLT3, IGF1R, KCNH2, KDR, MCL1, MET, MMP9, SLC6A4, TERT, TYR, XDH |
3.61137 |
|
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADRA2A, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC |
3.49823 |
|
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, SRC |
3.46474 |
|
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA12, CA14, CA2, CA4, CA7 |
3.31988 |
|
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FLT3, IGF1R, KDR, MET, PIM1, PPARA, SLC6A4, SRC |
3.30788 |
|
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, SRC |
3.29397 |
|
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.22712 |
|
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, TYR |
3.03875 |
|
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, HSD17B1, SRC, XDH |
2.89873 |
|
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.87831 |
|
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.827 |
|
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, SRC |
2.73738 |
|
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.72976 |
|
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.68063 |
|
[MF] GO:0008289 |
lipid binding
|
AXL, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HSD17B1, PPARA, RORC |
2.64998 |
|
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, CBR1, HSD17B1, HSD17B2 |
2.51518 |
|
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.46023 |
|
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A4 |
2.46023 |
|
[MF] GO:0047374 |
None
|
CES1, CES2 |
2.46023 |
|
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.21835 |
|
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, SRC |
2.20111 |
|
[MF] GO:0042803 |
protein homodimerization activity
|
ACHE, ADRA2A, AOX1, FLT3, KCNH2, MCL1, SLC6A4, TERT, TYR, XDH |
2.16757 |
|
[MF] GO:0038023 |
signaling receptor activity
|
ADRA2A, AXL, ESR1, ESR2, ESRRA, ESRRB, FLT3, IGF1R, KCNH2, KDR, MET, PPARA, RORC |
2.07175 |
|
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.0314 |
|
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIM1, SRC, TERT |
2.00786 |